Analysis of osteoprotegerin (OPG) gene polymorphism in Iranian patients with chronic periodontitis and peri-implantitis. A cross-sectional study

European Journal of Oral Implantology

Volumn 5, Issue 4, 2012, Pages 381-388

  Kadkhodazadeh, Mahdi ^a   Tabari, Zahra Alizadeh ^b   Talebi Ardakani, Mohammad Reza ^a   Ebadian, Ahmad Reza ^c   Brook, Azam ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Dentist   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gene polymorphism; Osteoprotegerin; Peri implantitis; Periodontitis

Indexed keywords

OSTEOPROTEGERIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CHRONIC PERIODONTITIS; CROSS-SECTIONAL STUDY; FEMALE; GENETICS; HUMAN; IRAN; MALE; PERIIMPLANTITIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRAN; MALE; OSTEOPROTEGERIN; PERI-IMPLANTITIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

MLCS; MLOWN;

EID: 84874811863     PISSN: 17562406     EISSN: 17562414     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Albrektsson T, Isidor F. Consensus report: implant therapy. In: Lang NP, Karring T (eds). Proceedings of the 1st European Workshop on Periodontology. Berlin: Quintessence Publishing, 1994:365-369.
2. Zitzmann NU, Berglundh T. Definition and prevalence of peri-implant diseases. J Clin Periodontol 2008;35:286-291.
3. Offenbacher S. Periodontal disease: pathogenesis. Ann Periodontol 1996;1:821-878.
4. Albandar JM. Global risk factors and risk indicators for periodontal disease. Periodontol 2000 2002;9:177-206.
5. Mombelli A, Lang NP. The diagnosis and treatment of periimplantitis. Periodontol 2000 1998;17:63-76.
6. Bregger U, Aeschlimann S, Burgin W, Hammerle CH, Lang NP. Biological and technical complications and failures with fixed partial dentures on implants and teeth after four to five years of function. Clin Oral Implants Res 2001;12:26-34.
7. Lindhe J, Meyle J. Peri-implant diseases: Consensus report of the Sixth European Workshop on Periodontology. J Clin Periodontol 2008;35(Suppl 8):282-285.
8. Michalowicz BS, Diehl SR, Gunsolley JC. Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol 2000;71:1699-1707.
9. Weyant RJ, Burt BA. An assessment of survival rates and within-patient clustering of failures for endosseous oral implants. J Dent Res 1993;72:2-8.
10. Baradaran-Rahimi H, Radvar M, Arab HR, Tavakol-Afshari J, Ebadian AR. Association of interleukin-1 receptor antagonist gene polymorphisms with generalized aggressive periodontitis in an Iranian population. J Periodontol 2010;81:1343-1347.
11. Kinane DF, Shiba H, Hart TC. The genetic basis of periodontitis. Periodontol 2000 2005;39:91-117.
12. Kadkhodazadeh M, Hajilooi M, Houshmand B, Khazaei S, Gholami L, Alijani S. Evaluation of PECAM-1 gene polymorphism in patients with periodontal disease and healthy individuals. ISRN Dent 2012;2012:751920.
13. Santos MC, Campos MI, Souza AP, Trevilatto PC, Line SR. Analysis of MMP-1 and MMP-9 promoter polymorphisms in early osseointegrated implant failure. Int J Oral Maxillofac Implants 2004;19:38-43.
14. Shimpuku H, Nosaka Y, Kawamura T, Tachi Y, Shinohara M, Ohura K. Bone morphogenetic protein-4 gene polymorphism and early marginal bone loss around endosseous implants. Int J Oral Maxillofac Implants 2003;18:500-504.
15. Shimpuku H, Nosaka Y, Kawamura T, Tachi Y, Shinohara M, Ohura K. Genetic polymorphisms of the IL-1 gene and early marginal bone loss around endosseous dental implants. Clin Oral Implants Res 2003;14:423-429.
16. Nosaka Y, Tachi Y, Shimpuku H, Kawamura T, Ohura K. Association of calcitonin receptor gene polymorphism with early marginal bone loss around endosseous implants. Int J Oral Maxillofac Implants 2002;17:38-43.
17. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-342.
18. Takayanagi H. Inflammatory bone destruction and osteoimmunology. J Periodontal Res 2005;40:287-293.
19. Crotti T, Smith MD, Hirsch R, Soukoulis S, Weedon H, Capone M, Ahern MJ, Haynes D. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 2003;38:380-387.
20. Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004;83:166-169.
21. Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela MA, Gamonal J. Levels of cytokine receptor activator of nuclear factor kappa-B ligand in gingival crevicular fluid in untreated chronic periodontitis patients. J Periodontol 2004;75:1586-1591.
22. Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Töz H, Atilla G, Hughes FJ, Belibasakis GN. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: Implications of their relative ratio. J Clin Periodontol 2007;34:370-376.
23. Morinaga T, Nakagawa N, Yasuda H, Tsuda E. Cloning and characterization of gene encoding human osteoprotegerin/ osteoclastogenesis-inhibitory factor. Eur J Biochem 1998;245:685-691.
24. Park OJ, Shin SY, Choi Y, Kim MH, Chung CP, Ku Y, Kim KK. The association of osteoprotegerin gene polymorphisms with periodontitis. Oral Dis 2008;14:440-444.
25. Soufi M, Schoppet M, Sattler AM, Herzum M, Maisch B, Hofbauer LC, Schaefer JR. Osteoprotegerin gene polymorphisms in men with coronary artery disease. J Clin Endocrinol Metab 2004;89:3764-3768.
26. Zhao HY, Liu JM, Ning G, Zhao YJ, Zhang LZ, Sun LH, Xu MY, Uitterlinden AG, Chen JL. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. Osteoporos Int 2005;16:1519-1524.
27. Wynne F, Drummond F, O'Sullivan K, Daly M, Shanahan F, Molloy MG, Quane KA. Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population. Calcif Tissue Int 2002;71:26-35.
28. Arikan F, Buduneli N, Kutukculer N. Osteoprotegrin levels in peri-implant crevicular fluid. Clin Oral Implants Res 2008;19:283-288.
29. Wagner J, Kaminski WE, Aslanidis C, Moder D, Hiller KA, Christgau M, Schmitz G, Schmalz G. Prevalence of OPG and IL-1 gene polymorphisms in chronic periodontitis. J Clin Periodontol 2007;34:823-827.
30. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
31. Ainamo J, Bay I. The visible plaque (VPI) and the gingival bleeding index (GBI) system. J Clin Periodontol;1975. 32. Qyirynen M, De Soete M, Van Steenberghe D. Infectious risks for oral implants. Clin Oral Implants Res 2002;13:1-19.
32. Kadkhodazadeh M, Amid R. Evaluation of peri-implant tissue health using a scoring system. Journal of Implant & Advanced Clinical Dentistry 2012;4:51-57.
33. Langdahl B, Carstens M, Stenkjaer L, Eriksen E. Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J Bone Miner Res 2002;17:1245-1255.
34. Little J, Higgins JPT, Ioannidis JPA, Moher D, Gagnon F, von Elm E, et al. STrengthening the REporting of Genetic Association studies (STREGA) - an extension of the STROBE statement. Eur J Clin Invest 2009;39:247-266.
35. Wohlfahrt J, Tianxia WU, Hodges J, Hinrichs J, Michalowicz B. No association between selected candidate gene polymorphisms and severe chronic periodontitis. J Periodontol 2006;77:426-436.
36. Baioni CS, De souza CM, Ribeiro Braosi AP, Luczyszym SM, Dias da silva MA, Ignasio SA, Naval Machado MA, Benato Martins WD, Riella MC, Pecoits-Filho R, Trevilatto PC. Analysis of association of polymorphism in osteoprotegrin gene with susceptibility to chronic kidney disease and periodontitis. J Periodontal Res 2008;43:578-584.
37. Ohmori H, Makita Y, Funamizu M. Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis. J Hum Genet 2002;47:400-406.
38. Vidal C, Brincat M, Xuereb Anastasi A. TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta. Maturitas 2006;53:386-395.
39. Ueland T, Bollerslev J, Wilson SG, Dick IM, Islam FM, Mullin BH, Devine A, Prince RL. No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women. Bone 2007;40: 175-181.
40. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. Mol Biol Rep 2010;37:227-234.
41. Ferreira SD, Silva GLM, Cortelli JR, Costa JE, Costa FO. Prevalence and risk variables for peri-implant disease in Brazilian subjects. J Clin Periodontol 2006;33:929-935.
42. Roos-Jansaker AM, Lindahl C, Renvert H, Renvert S. Nine- to fourteen-year follow-up of implant treatment. Part II: Presences of peri implant lesions. J Clin Periodontol 2006;33:290-295.
43. Misch CE, Perel ML, Wang HL, Sammartino G, Galindo- Moreno P, Trisi P, Steigmann M, Rebaudi A, Palti A, Pikos MA, Schwartz-Arad D, Choukroun J, Gutierrez- Perez JL, Marenzi G, Valavanis DK. Implant success, survival, and failure: the international congress of oral implantologists (ICOI) pisa consensus conference. Implant Dent 2008;17: 5-15.
44. Esposito M, Murray-Curtis L, Grusovin MG, Coulthard P, Worthington HV. Interventions for replacing missing teeth: different types of dental implants. Cochrane Database Syst Rev 2007;(4):CD003815.
45. Hamdy AA, Ebrahem MA. The effect of interleukin-1 allele 2 genotype (IL-1a (-889) and IL-1b (+3954)) on the individual's susceptibility to peri-implantitis: case-control study. J Oral Implantol 2011;37:325-334.
46. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1.